Edwards F R, Whitwell F
Thorax. 1978 Apr;33(2):250-2. doi: 10.1136/thx.33.2.250.
Sixty consecutive surviving patients treated with subdermal BCG (5 X 10(6) organisms) have been followed up for five years after resection of lung carcinoma. A control group of the previous 60 consecutive surviving patients not treated with BCG was similarly studied. We found no statistical evidence that the administration of BCG by the method described influenced the five-year survival rate, nor has any effective action upon involved lymph nodes or small metastases been demonstrated.
连续60例接受皮下注射卡介苗（5×10⁶个菌体）治疗的肺癌切除术后存活患者已被随访五年。对之前连续60例未接受卡介苗治疗的存活患者组成的对照组进行了类似研究。我们没有发现统计学证据表明按所述方法给予卡介苗会影响五年生存率，也未证明其对受累淋巴结或微小转移灶有任何有效作用。
